Protara Therapeutics Inc (TARA)
3.10
-0.64
(-17.11%)
USD |
NASDAQ |
May 17, 16:00
3.10
0.00 (0.00%)
After-Hours: 20:00
Protara Therapeutics Shareholders Equity (Quarterly): 58.41M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 58.41M |
December 31, 2023 | 68.32M |
September 30, 2023 | 76.96M |
June 30, 2023 | 85.22M |
March 31, 2023 | 94.77M |
December 31, 2022 | 102.08M |
September 30, 2022 | 139.18M |
June 30, 2022 | 145.46M |
March 31, 2022 | 152.24M |
December 31, 2021 | 161.91M |
Date | Value |
---|---|
September 30, 2021 | 170.41M |
June 30, 2021 | 178.40M |
March 31, 2021 | 188.13M |
December 31, 2020 | 199.24M |
September 30, 2020 | 194.63M |
June 30, 2020 | 59.43M |
March 31, 2020 | 64.74M |
December 31, 2019 | -2.128M |
September 30, 2019 | 51.91M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-2.128M
Minimum
Dec 2019
199.24M
Maximum
Dec 2020
115.23M
Average
102.08M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
AngioDynamics Inc | 218.70M |
Regulus Therapeutics Inc | 107.59M |
Bio-Path Holdings Inc | 0.441M |
Outset Medical Inc | 93.20M |
NovaBay Pharmaceuticals Inc | 0.16M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 68.13M |
Total Liabilities (Quarterly) | 9.728M |